Skip to main content

Table 7 Distribution of first events by treatment modality: CCLG patients

From: Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92

  Local treatment modality, N (%) Total
Surgery alone
N = 70
RT alone
N = 81
RT then surgery
N = 6
Surgery then RT
N = 32
None
N = 18
Unknown
N = 3
No event 41 (59) 31 (38) 2 (33) 14 (44) 0 2 (67) 90
Local recurrence 5 (7.1) 12 (15) 1 (17) 1 (3.1) 10 (56) 0 29
Distant recurrence 18 (26) 28 (35) 1 (17) 13 (41) 5 (28) 1 (33) 66
Local and distant 3 (4.3) 6 (7.4) 2 (33) 3 (9.4) 2 (11) 0 13
Relapse-unspecified 0 0 0 0 0 0 0
Second malignancy 1 (1.4) 1 (1.2) 0 0 0 0 2
Death—no relapse 2 (2.9) 3 (3.7) 0 1 (3.1) 1 (5.6) 0 7
All deaths 24 (34) 45 (56) 4 (67) 15 (47) 16 (89) 1 (33) 105
  1. RT radiotherapy